Cra

Lindus Health, a NYC-based clinical trial company, raised $55M in Series B funding led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp. The funds will enhance their AI technology and eClinical platform, Citrus™, for optimizing study design and data monitoring. Since its 2021 launch, Lindus Health has conducted 42 trials, enrolling over 36,000 patients in North America and Europe.

NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched their "all-in-one" contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.Cardiovascular disease is the leading cause of death in both men and women as well as most racial groups in the US. Clinical trials for these conditions require large, diverse participant populations to capture variability in disease presentation and risk factors, along with extended follow-up to assess long-term outcomes and quality of life improvements. Implementing patient-centric approaches in these studies, like remote-monitoring or decentralized trial designs, is also critical to reduce barriers to participation and observe how these interventions perform in the real world. Lindus Health's latest offering equips sponsors with all the necessary resources to navigate these distinct challenges and more that come with conducting clinical trials in the cardiovascular space.To date, Lindus Health has enrolled over 8,000 patients in cardiovascular studies across the US, UK, and EU. Their "All-in-One Cardiovascular CRO" includes end-to-end CRO and site services, industry knowledge, and eClinical technology necessary for sponsors developing therapies and devices to treat and monitor cardiovascular indications."Patient experience is paramount in cardiovascular studies," said Meri Beckwith, co-founder at Lindus Health

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has introduced their versatile contract research organization (CRO), site, and technology offering tailor-made to the execution of infectious disease trials.Clinical development of infectious disease treatments and diagnostics must account for complexities such as diverse and evolving pathogens, seasonality and localization of study sites, and enrollment at the appropriate time during infection. Having enrolled over 5,000 patients in infectious disease studies across the US, EU, and UK, Lindus Health is well-equipped to handle the unique challenges within this therapeutic area.Lindus Health's latest solution for the infectious disease market segment leverages their full-spectrum CRO and site services, rooted in deep expertise in running infectious disease clinical trials. They are able to recruit diverse study populations at twice the speed of traditional CROs through their expansive recruitment capabilities, including targeted digital outreach campaigns, healthcare and community organization collaborations, and electronic health record (EHR) screening from a repository of over 30 million patients."Infectious disease studies require swift and adaptable approaches for execution and recruitment to keep pace with evolving pathogens and public health needs," said Meri Beckwith, co-founder of Lindus Health. "Therefore speed of execution and access to real-time data are essential, while ensuring enrollment of diverse and representative patient populations."The "All-in-One Infectious Disease CRO" offers a comprehensive suite of resources and services to support infectious disease research, including:Full-service CRO solutions: From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities.From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities. Innovative recruitment strategies : With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies.: With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies